Cookie Policy

By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.

Bringing clinical trials home:

How virtual research can reduce patient burden & improve outcomes.

We presented our pioneering DCT with RedHill Biopharma in front of 500+ senior executives from big pharma – offering a roadmap to at-home monitoring of infectious disease. By pairing FDA-approved devices with our patient-friendly virtual study platform and app, we’ve enabled remote monitoring of patient vitals formerly confined to the lab or clinic. Since most COVID-19 patients are recovering from illness at home, we’ve brought the research setting to them. Our presentation highlights the study design of this groundbreaking remote clinical trial.

Interested in Viewing the Webinar?

Fill out the form below for access.

Virtual Trial Journey

A Seamless End-to-End Experience

ObvioHealth studies are run on our purpose-built platform by our own in-house virtual team. This allows us to work seamlessly from protocol design all the way through to analysis and reporting.

ObvioHealth's Numbers

Up to 4x

Faster Recruitment

3 mo ObvioHealth average vs 12 mo benchmark for site-based trials


Retention Rate

average retention vs. 70% benchmark for traditional trials


ePro Compliance

average per study (digital questionnaires, daily ediary, etc.).

Our Client Roster

A. Vogel Logo.
Anatara logo.
Bayer logo.
Danoone Logo.
DSM logo.
entrinsic health logo.
Friesland campina logo.
General mills logo.
Janssen logo.
Lycored logo.
mithra logo.
Mizkan logo.
pfizer logo.
RedHill Biopharma Logo.
Renovia Logo.
Left Carousel Arrow icon.
Right carousel arrow icon.

Leverage Next Gen Solutions in Your Next DCT

Learn More